MUMBAI, India, May 30 -- Intellectual Property India has published a patent application (202518021830 A) filed by ationwide Children's Hospital Inc.; and Ohio State Innovation Foundation, Columbus, U.S.A., on March 11, for 'intrathecal delivery of recombinant adeno-associated virus encoding methyl-cpg binding protein 2.'
Inventor(s) include Foust, Kevin; and Kaspar, Brian, K.
The application for the patent was published on May 30, under issue no. 22/2025.
According to the abstract released by the Intellectual Property India: "Methods and materials for intrathecal delivery of recombinant Adeno-associated virus 9 (rAAV9) encoding Methyl-CpG binding protein 2 (MECP2) are provided. Use of the methods and materials is contemplated, for example, for the treatment of Rett syndrome."
The patent application was internationally filed on Nov. 17, 2017, under International application No.PCT/US2017/062371.
Disclaimer: Curated by HT Syndication.
